ROBIN HAWTHORNE: Open Payments
NPI 1669868691 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 79 payments from 14 companies in 2025. Trend: 2023 $552 · 2024 $1,067 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $325 |
| AstraZeneca Pharmaceuticals LP | 16 | $314 |
| Novo Nordisk Inc | 11 | $177 |
| EVOKE PHARMA, INC. | 5 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| Abbott Laboratories | 1 | $78 |
| Amgen Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $29 |
| Dexcom, Inc. | 1 | $24 |
Products named: UBRELVY, AIRSUPRA, GIMOTI, CAPLYTA, BREZTRI, Rybelsus, JARDIANCE, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
